Filing Flows › Impact Biomedical (IBO) › Q2 2026 › vs Q1 2026
Impact Biomedical (IBO) Q2 2026 vs Q1 2026 (quarter over quarter)
Impact Biomedical's revenue fell $4K (-57%) from $7K in Q1 2026 to $3K in Q2 2026.
Impact Biomedical, Q2 2026: revenue $3K (-57% year over year), net loss $700K, operating cash flow $470K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $3K | $7K | −$4K | -57% |
| Other income, net | $2K | $5K | −$3K | -60% |
| Net loss | $700K | $2.3M | −$1.6M | -69% |
| Costs & expenses | $705K | $2.3M | −$1.6M | -69% |
| Operating costs | $705K | $2.3M | −$1.6M | -69% |
| Research & development | $76K | $46K | $30K | +65% |
| SG&A | $167K | $1.6M | −$1.5M | -90% |
| Other operating costs | $461K | $630K | −$169K | -27% |
| Operating cash sources | $1.2M | $380K | $790K | +208% |
| Depreciation & amortization | $284K | $285K | −$1K | -0.4% |
| Working capital & other | $886K | $95K | $791K | +833% |
| Net loss absorbed | $700K | $2.3M | −$1.6M | -69% |
| Operating cash flow | $470K | −$464K | $934K | — |
Questions
How much did Impact Biomedical's revenue grow quarter over quarter in Q2 2026?
Impact Biomedical's revenue fell $4K (-57%) from $7K in Q1 2026 to $3K in Q2 2026.